Clinical Trials
3 trialsNCT05243550 2026-05-11
ENVISION
UroGen Pharma Ltd.
Phase 3 Active not recruiting
NCT06331299 2026-01-15
UTOPIA
UroGen Pharma Ltd.
Phase 3 Active not recruiting
NCT06462001 2024-06-17
BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
Nottingham University Hospitals NHS Trust
Phase 3 Active not recruiting